|
|
||||||||
The Journal of Immunology, Vol 143, Issue 1 103-112, Copyright © 1989 by American Association of Immunologists
ARTICLES |
S Shivakumar, GC Tsokos and SK Datta
Department of Medicine, New England Medical Center, Boston, MA 02111.
It is generally accepted that human Th cells express the surface glycoproteins CD4 and alpha/beta-chain heterodimer of the TCR whereas cytotoxic/suppressor cells are usually CD8+ and alpha/beta TCR+. Another minor set of T cells found in the periphery are CD4-/CD8- (double negative) and express the gamma/delta TCR; these cells can manifest MHC-restricted or nonrestricted cytotoxicity but no helper function. Herein we describe the existence of an unusual Th population in the peripheral blood of humans that are CD4-/CD8- and alpha/beta TCR+. These double-negative Th were markedly expanded in patients with the autoimmune disease SLE and along with CD4+ Th, they induced production of the pathogenic variety of anti-DNA autoantibodies that are IgG in class and cationic in charge. The cationic anti-DNA antibodies induced by the Th were markedly restricted in spectrotype indicating that an oligoclonal population of B cells were committed to produce the pathogenic autoantibodies in active lupus. IL-2-dependent T cell lines were also derived from the patients with active lupus nephritis but the majority of those T cell lines lacked pathogenic autoantibody-inducing capability. Only 4 out of 42 T cell lines from a lupus patient could induce the production of cationic IgG class anti- DNA autoantibodies. The phenotypes of the pathogenic autoantibody- inducing Th lines were similar to the Th subsets: CD4+, alpha/beta TCR+ or CD4-/CD8-, alpha/beta TCR+. These studies suggest that production of pathogenic autoantibodies in human lupus is mediated by mechanisms that are distinct from the generalized, nonspecific polyclonal B cell hyperactivity that leads to excessive production of natural autoantibodies.
This article has been cited by other articles:
![]() |
J. C. Crispin, M. Oukka, G. Bayliss, R. A. Cohen, C. A. Van Beek, I. E. Stillman, V. C. Kyttaris, Y.-T. Juang, and G. C. Tsokos Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys J. Immunol., December 15, 2008; 181(12): 8761 - 8766. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Teachey, A. E. Seif, V. I. Brown, M. Bruno, R. M. Bunte, Y. J. Chang, J. K. Choi, J. D. Fish, J. Hall, G. S. Reid, et al. Targeting Notch signaling in autoimmune and lymphoproliferative disease Blood, January 15, 2008; 111(2): 705 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Illes, H. Waldner, J. Reddy, A. C. Anderson, R. A. Sobel, and V. K. Kuchroo Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background Int. Immunol., October 1, 2007; 19(10): 1235 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Munoz, U. S. Gaipl, S. Franz, A. Sheriff, R. E. Voll, J. R. Kalden, and M. Herrmann SLE--a disease of clearance deficiency? Rheumatology, September 1, 2005; 44(9): 1101 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fischer, S. Voelkl, J. Heymann, G. K. Przybylski, K. Mondal, M. Laumer, L. Kunz-Schughart, C. A. Schmidt, R. Andreesen, and A. Mackensen Isolation and characterization of human antigen-specific TCR{alpha}{beta}+ CD4-CD8- double-negative regulatory T cells Blood, April 1, 2005; 105(7): 2828 - 2835. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Kang, M. A. Michaels, B. R. Berner, and S. K. Datta Very Low-Dose Tolerance with Nucleosomal Peptides Controls Lupus and Induces Potent Regulatory T Cell Subsets J. Immunol., March 15, 2005; 174(6): 3247 - 3255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Cappione, A. E. Pugh-Bernard, J. H. Anolik, and I. Sanz Lupus IgG VH4.34 Antibodies Bind to a 220-kDa Glycoform of CD45/B220 on the Surface of Human B Lymphocytes J. Immunol., April 1, 2004; 172(7): 4298 - 4307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Q. Yang, A. K. Singh, M. T. Wilson, M. Satoh, A. K. Stanic, J.-J. Park, S. Hong, S. D. Gadola, A. Mizutani, S. R. Kakumanu, et al. Immunoregulatory Role of CD1d in the Hydrocarbon Oil-Induced Model of Lupus Nephritis J. Immunol., August 15, 2003; 171(4): 2142 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Viret and C. A. Janeway Jr. Self-Specific MHC Class II-Restricted CD4-CD8- T Cells That Escape Deletion and Lack Regulatory Activity J. Immunol., January 1, 2003; 170(1): 201 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Anand, G S Dean, K Quereshi, D A Isenberg, and P M Lydyard Characterization of CD3+CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers Lupus, August 1, 2002; 11(8): 493 - 500. [Abstract] [PDF] |
||||
![]() |
R Yung, M Kaplan, D Ray, K Schneider, R-R Mo, K Johnson, and B Richardson Autoreactive murine Th1 and Th2 cells kill syngeneic macrophages and induce autoantibodies Lupus, August 1, 2001; 10(8): 539 - 546. [Abstract] [PDF] |
||||
![]() |
H. Sekine, C. M. Reilly, I. D. Molano, G. Garnier, A. Circolo, P. Ruiz, V. M. Holers, S. A. Boackle, and G. S. Gilkeson Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice J. Immunol., May 15, 2001; 166(10): 6444 - 6451. [Abstract] [Full Text] [PDF] |
||||
![]() |
D A Horwitz Peripheral blood CD4/ T cells in systemic lupus erythematosus Lupus, May 1, 2001; 10(5): 319 - 320. [PDF] |
||||
![]() |
Y. Yi, M. McNerney, and S. K. Datta Regulatory Defects in Cbl and Mitogen-Activated Protein Kinase (Extracellular Signal-Related Kinase) Pathways Cause Persistent Hyperexpression of CD40 Ligand in Human Lupus T Cells J. Immunol., December 1, 2000; 165(11): 6627 - 6634. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Sieling, S. A. Porcelli, B. T. Duong, F. Spada, B. R. Bloom, B. Diamond, and B. H. Hahn Human Double-Negative T Cells in Systemic Lupus Erythematosus Provide Help for IgG and Are Restricted by CD1c J. Immunol., November 1, 2000; 165(9): 5338 - 5344. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Stoll and J. Gavalchin Systemic lupus erythematosus--messages from experimental models Rheumatology, January 1, 2000; 39(1): 18 - 27. [Full Text] [PDF] |
||||
![]() |
C. Mohan, Y. Yu, L. Morel, P. Yang, and E. K. Wakeland Genetic Dissection of Sle Pathogenesis: Sle3 on Murine Chromosome 7 Impacts T Cell Activation, Differentiation, and Cell Death J. Immunol., June 1, 1999; 162(11): 6492 - 6502. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Mixter, J. Q. Russell, G. J. Morrissette, C. Charland, D. Aleman-Hoey, and R. C. Budd A Model for the Origin of TCR-{alpha}{beta}+ CD4-CD8- B220+ Cells Based on High Affinity TCR Signals J. Immunol., May 15, 1999; 162(10): 5747 - 5756. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Fraser, L-Y Lu, K DeCeulaer, P H Schur, D Fici, Z Awdeh, W-Z Ding, E Levitan, R Lew, G Uko, et al. CD4 TCRBV CDR3 Analysis in prevalent SLE Cases from two ethnic Groups Lupus, May 1, 1999; 8(4): 311 - 319. [Abstract] [PDF] |
||||
![]() |
K Ohtsuka, J D Gray, F P Quismorio Jr, W Lee, and D A Horwitz Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta Lupus, February 1, 1999; 8(2): 95 - 102. [Abstract] [PDF] |
||||
![]() |
E. G. Brooks, A. H. Filipovich, J. W. Padgett, R. Mamlock, and R. M. Goldblum T-Cell Receptor Analysis in Omenn's Syndrome: Evidence for Defects in Gene Rearrangement and Assembly Blood, January 1, 1999; 93(1): 242 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
S K Datta Production of pathogenic antibodies: Cognate interactions between autoimmune T and B cells Lupus, November 1, 1998; 7(9): 591 - 596. [Abstract] [PDF] |
||||
![]() |
M. S. Lim, S. E. Straus, J. K. Dale, T. A. Fleisher, M. Stetler-Stevenson, W. Strober, M. C. Sneller, J. M. Puck, M. J. Lenardo, K. S. J. Elenitoba-Johnson, et al. Pathological Findings in Human Autoimmune Lymphoproliferative Syndrome Am. J. Pathol., November 1, 1998; 153(5): 1541 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
B H Hahn, R R Singh, and F M Ebling Self Ig peptides that help anti-DNA antibody production: importance of charged residues Lupus, June 1, 1998; 7(5): 307 - 313. [Abstract] [PDF] |
||||
![]() |
S. Yamagiwa, S. Sugahara, T. Shimizu, T. Iwanaga, Y. Yoshida, S. Honda, H. Watanabe, K. Suzuki, H. Asakura, and T. Abo The Primary Site of CD4-8-B220+ {alpha}{beta} T Cells in lpr Mice: The Appendix in Normal Mice J. Immunol., March 15, 1998; 160(6): 2665 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Kalled, A. H. Cutler, S. K. Datta, and D. W. Thomas Anti-CD40 Ligand Antibody Treatment of SNF1 Mice with Established Nephritis: Preservation of Kidney Function J. Immunol., March 1, 1998; 160(5): 2158 - 2165. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Sirianni, L. Vincenzi, V. Fiorelli, S. Topino, E. Scala, S. Uccini, A. Angeloni, A. Faggioni, D. Cerimele, F. Cottoni, et al. gamma -Interferon Production in Peripheral Blood Mononuclear Cells and Tumor Infiltrating Lymphocytes From Kaposi's Sarcoma Patients: Correlation With the Presence of Human Herpesvirus-8 in Peripheral Blood Mononuclear Cells and Lesional Macrophages Blood, February 1, 1998; 91(3): 968 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Sneller, J. Wang, J. K. Dale, W. Strober, L. A. Middelton, Y. Choi, T. A. Fleisher, M. S. Lim, E. S. Jaffe, J. M. Puck, et al. Clinical, Immunologic, and Genetic Features of an Autoimmune Lymphoproliferative Syndrome Associated With Abnormal Lymphocyte Apoptosis Blood, February 15, 1997; 89(4): 1341 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ben-Yehuda, R. Bar-Tana, A. Livoff, N. Ron, I. Cohen, and Y. Naparstek Lymph node cell vaccination against the lupus syndrome of MRL/lpr/lpr mice Lupus, June 1, 1996; 5(3): 232 - 236. [Abstract] [PDF] |
||||
![]() |
T.H. Winkler and J.R. Kalden Origin of Anti-DNA Autoantibodies in SLE Lupus, April 1, 1994; 3(2): 75 - 76. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |